Clinuvel Pharmaceuticals Ltd banner

Clinuvel Pharmaceuticals Ltd
OTC:CLVLF

Watchlist Manager
Clinuvel Pharmaceuticals Ltd Logo
Clinuvel Pharmaceuticals Ltd
OTC:CLVLF
Watchlist
Price: 6.1 USD -4.69% Market Closed
Market Cap: $305.6m

Wall St Price Targets

CLVLF Price Targets Summary
Clinuvel Pharmaceuticals Ltd

Wall Street analysts forecast CLVLF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLVLF is 16.71 USD with a low forecast of 9.05 USD and a high forecast of 28.37 USD.

Lowest Forecast
Price Target
9.05 USD
48% Upside
Average Forecast
Price Target
16.71 USD
174% Upside
Highest Forecast
Price Target
28.37 USD
365% Upside
Clinuvel Pharmaceuticals Ltd Competitors:
Price Targets
1981
Cathay Media and Education Group Inc
60% Upside
INBK
First Internet Bancorp
3% Upside
RLMD
Relmada Therapeutics Inc
115% Upside

Revenue
Forecast

39% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
39% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 39%. The projected CAGR for the next 8 years is 8%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Clinuvel Pharmaceuticals Ltd

Operating Income
Forecast

N/A
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

The compound annual growth rate for Operating Income over the next 8 years is 9%.

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Clinuvel Pharmaceuticals Ltd

Net Income
Forecast

N/A
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

The compound annual growth rate for Net Income over the next 8 years is 10%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CLVLF's stock price target?
Price Target
16.71 USD

According to Wall Street analysts, the average 1-year price target for CLVLF is 16.71 USD with a low forecast of 9.05 USD and a high forecast of 28.37 USD.

What is the Revenue forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Revenue has been 39%. The projected CAGR for the next 8 years is 8%.

What is the Operating Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
9%

The compound annual growth rate for Operating Income over the next 8 years is 9%.

What is the Net Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
10%

The compound annual growth rate for Net Income over the next 8 years is 10%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett